Seed Wealth Management’s AbbVie ABBV Stock Holding History

Seed Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-892	Closed	-$204K	–	99
2025 Q4	$204K	Sell	892 -22	-2%	-$5.01K	0.14%	100
2025 Q3	$212K	Sell	914 -464	-34%	-$94.5K	0.15%	105
2025 Q2	$256K	Hold	1,378	–	–	0.19%	123
2025 Q1	$289K	Hold	1,378	–	–	0.24%	108
2024 Q4	$245K	Hold	1,378	–	–	0.2%	126
2024 Q3	$272K	Hold	1,378	–	–	0.22%	120
2024 Q2	$236K	Hold	1,378	–	–	0.21%	124
2024 Q1	$249K	Hold	1,378	–	–	0.24%	112
2023 Q4	$220K	Hold	1,378	–	–	0.22%	125
2023 Q3	$205K	Buy	+1,378	New	+$202K	0.23%	126
2023 Q2	–	Sell	-1,378	Closed	-$220K	–	141
2023 Q1	$220K	Hold	1,378	–	–	0.25%	120
2022 Q4	$223K	Buy	+1,378	New	+$211K	0.26%	106

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seed Wealth Management's ABBV Position: Q1 2026 in Review

Seed Wealth Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 892 shares — an estimated $204K sold.

Seed Wealth Management first reported a position in ABBV in Q4 2022 and held it in 12 quarters. The position peaked at $289K in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Seed Wealth Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Seed Wealth Management sold 892 AbbVie shares in Q1 2026, an estimated $204K.
Seed Wealth Management first reported a position in AbbVie in Q4 2022 and held it in 12 quarters.
Seed Wealth Management's AbbVie position peaked at $289K in Q1 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Seed Wealth Management's 13F filing for Q1 2026, filed 8 Apr 2026.